NO20022123D0 - Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII - Google Patents

Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII

Info

Publication number
NO20022123D0
NO20022123D0 NO20022123A NO20022123A NO20022123D0 NO 20022123 D0 NO20022123 D0 NO 20022123D0 NO 20022123 A NO20022123 A NO 20022123A NO 20022123 A NO20022123 A NO 20022123A NO 20022123 D0 NO20022123 D0 NO 20022123D0
Authority
NO
Norway
Prior art keywords
oxoxazole
inhibitors
derivatives
phosphodiesterase vii
phosphodiesterase
Prior art date
Application number
NO20022123A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022123L (no
Inventor
Hans-Michael Eggenweiler
Rochus Jonas
Michael Wolf
Michael Gassen
Thomas Welge
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20022123L publication Critical patent/NO20022123L/no
Publication of NO20022123D0 publication Critical patent/NO20022123D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
NO20022123A 1999-11-04 2002-05-03 Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII NO20022123D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19953024A DE19953024A1 (de) 1999-11-04 1999-11-04 Isoxazolderivate als Phosphodiesterase VII-Hemmer
PCT/EP2000/010239 WO2001032175A1 (de) 1999-11-04 2000-10-18 Isoxazolderivate als phosphodiesterase vii-hemmer

Publications (2)

Publication Number Publication Date
NO20022123L NO20022123L (no) 2002-05-03
NO20022123D0 true NO20022123D0 (no) 2002-05-03

Family

ID=7927860

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022123A NO20022123D0 (no) 1999-11-04 2002-05-03 Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII

Country Status (20)

Country Link
US (1) US6531498B1 (pl)
EP (1) EP1225896B1 (pl)
JP (1) JP2003513042A (pl)
KR (1) KR20020047329A (pl)
CN (1) CN1384744A (pl)
AR (1) AR026350A1 (pl)
AT (1) ATE300945T1 (pl)
AU (1) AU781607B2 (pl)
BR (1) BR0015333A (pl)
CA (1) CA2389647C (pl)
CZ (1) CZ20021441A3 (pl)
DE (2) DE19953024A1 (pl)
ES (1) ES2243313T3 (pl)
HU (1) HUP0203187A3 (pl)
MX (1) MXPA02004441A (pl)
NO (1) NO20022123D0 (pl)
PL (1) PL355021A1 (pl)
RU (1) RU2002113746A (pl)
SK (1) SK5942002A3 (pl)
WO (1) WO2001032175A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008001A1 (en) * 1998-08-07 2000-02-17 Chiron Corporation Substituted isoxazole as estrogen receptor modulators
ES2217956B1 (es) * 2003-01-23 2006-04-01 Almirall Prodesfarma, S.A. Nuevos derivados de 4-aminotieno(2,3-d)pirimidin-6-carbonitrilo.
US20050107350A1 (en) * 2003-08-22 2005-05-19 Pharmacia Corporation Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith
KR100666052B1 (ko) * 2004-02-12 2007-01-09 조극래 원적외선이용한 건조장치
AU2006274968B2 (en) * 2005-07-29 2012-02-23 Basf Se Stabilization of body-care and household products against degradation by UV radiation using merocyanine derivatives
WO2008119057A2 (en) * 2007-03-27 2008-10-02 Omeros Corporation The use of pde7 inhibitors for the treatment of movement disorders
US8637528B2 (en) 2007-03-27 2014-01-28 Omeros Corporation Use of PDE7 inhibitors for the treatment of movement disorders
US9220715B2 (en) 2010-11-08 2015-12-29 Omeros Corporation Treatment of addiction and impulse-control disorders using PDE7 inhibitors
KR20130124333A (ko) 2010-11-08 2013-11-13 오메로스 코포레이션 Pde7 억제제를 사용한 중독 및 충동-조절 장애의 치료
CN104725329B (zh) * 2015-01-13 2017-01-18 陕西科技大学 一种具有抗肿瘤活性的异恶唑羧酸类化合物及其合成方法
US11685745B2 (en) 2017-07-12 2023-06-27 Dart Neuroscience, Llc Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors
AU2023326563A1 (en) 2022-08-18 2025-02-27 Mitodicure Gmbh Use of a therapeutic agent with phosphodiesterase-7 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633254A1 (en) * 1991-05-01 1995-01-11 Taiho Pharmaceutical Co., Ltd. Novel isoxazole derivative and salt thereof
EP0730587B1 (en) * 1993-11-26 1999-12-08 Pfizer Inc. 3-phenyl-2-isoxazolines as antiinflammatory agents
ATE154932T1 (de) 1993-11-26 1997-07-15 Pfizer Isoxazolinverbindungen als entzündungshemmende mittel

Also Published As

Publication number Publication date
JP2003513042A (ja) 2003-04-08
PL355021A1 (pl) 2004-03-22
ATE300945T1 (de) 2005-08-15
ES2243313T3 (es) 2005-12-01
HUP0203187A2 (hu) 2003-01-28
DE50010885D1 (de) 2005-09-08
DE19953024A1 (de) 2001-05-10
HUP0203187A3 (en) 2004-12-28
CN1384744A (zh) 2002-12-11
BR0015333A (pt) 2002-07-09
AU781607B2 (en) 2005-06-02
NO20022123L (no) 2002-05-03
EP1225896A1 (de) 2002-07-31
WO2001032175A1 (de) 2001-05-10
AR026350A1 (es) 2003-02-05
CA2389647C (en) 2010-08-10
AU1026201A (en) 2001-05-14
SK5942002A3 (en) 2002-09-10
RU2002113746A (ru) 2004-01-10
CZ20021441A3 (cs) 2002-07-17
KR20020047329A (ko) 2002-06-21
MXPA02004441A (es) 2004-09-10
EP1225896B1 (de) 2005-08-03
US6531498B1 (en) 2003-03-11
CA2389647A1 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
DK1289985T3 (da) Beta-carbolinderivater anvendelige som phosphodiesteraseinhibitorer
NO20022125D0 (no) Pyrrolderivater som inhibitorer for fosfodiesterase VII
NO20023828L (no) Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer
DK1244647T3 (da) Quinzolinderivater som VIGF-inhibitorer
NO20021239L (no) Pteridinoner som kinase-inhibitorer
ATE278690T1 (de) Substituierte pyprolopyridinonderivate als phosphodiesterase-inhibitoren
NO20030867D0 (no) Hydroksamderivater anvendelig som deacetylaseinhibitorer
NO20021329L (no) Kinaseinhibitorer som terapeutiske midler
DK1226143T3 (da) Imidazopyridinderivater som phosphodiesterase VII-inhibitorer
NO20033618D0 (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
NO20022232D0 (no) Imidazolforbindelser for anvendelse som inhibitorer for fosfodiesterase VII
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
NO20010331D0 (no) Ftalazinderivater som fosfodiesterase 4-inhibitorer
NO20021959D0 (no) Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer
NO20016403D0 (no) Substituerte purinderivater som inhibitorer av celleadhesjon
ATE300945T1 (de) Isoxazolderivate als phosphodiesterase vii-hemmer
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
DK1222193T3 (da) Imidazolderivater som phosphodiesterase VII-inhibitorer
ATE262517T1 (de) Thiopyranderivate as mmp-inhibitoren
NO20015033L (no) Anvendelse av maduraftalazinderivater som inhibitorer av proinflammatoriske cytokiner
DK1296981T3 (da) Substituerede pyrrolopyridinonderivater som phosphodiesteraseinhibitorer
NO20020592D0 (no) Fluorenderivater som integrininhibitorer
SI1289985T1 (en) Beta-carboline derivatives useful as inhibitors of phosphodiesterase
SI1226143T1 (en) Imidazopyridine derivatives used as phosphodiesterase vii inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application